Norman Noble adds engineering design services for medical implants

Norman Noble, Inc., Highland Heights, Ohio, announced in February 2026 the addition of engineering design services to its medical-implant manufacturing portfolio. The new offering supports customers developing implantable devices that require advanced laser machining of nitinol, cobalt-chromium, titanium, and other high-performance alloys, and lets device makers partner with Norman Noble at the earliest stages of product development.

Through the engineering design service, Norman Noble’s team works with customers on drawing specifications, design for manufacturability, prototyping strategy, and process development with the goal of moving from concept to validated prototype faster than is typical with sequential outsourcing. The capability builds on the company’s existing offerings in laser machining, athermal Noble STEALTH laser processing, Noble SynchroFlash, and Noble DryEPolish surface finishing — all of which are already used across the cardiovascular, structural heart, neurovascular, and orthopedic implant markets.

By adding upfront design support, Norman Noble strengthens its position as a contract development and manufacturing organization (CDMO) for complex implantable devices. The expansion reflects increasing customer demand for integrated end-to-end partners that can carry a device from early concept through validated production, particularly for nitinol implants where design choices and manufacturing methods are tightly coupled.

Norman Noble, Inc. is a privately held precision contract manufacturer headquartered in Highland Heights, Ohio. The company specializes in laser machining and finishing of nitinol and other implant-grade alloys, and supports the development and manufacture of finished medical implants for global medical device customers.

Read further here

FDA approves JenaValve Trilogy transcatheter heart valve for aortic regurgitation

JenaValve Technology, Irvine, California, received U.S. Food and Drug Administration approval on March 23, 2026 for the Trilogy Heart Valve System for the treatment of symptomatic severe aortic regurgitation in patients deemed at high or greater risk for surgical aortic valve replacement. Trilogy is the first and only transcatheter heart valve approved in the United States for aortic regurgitation, addressing a long-standing unmet need in structural heart medicine.

The Trilogy device is a self-expanding, transcatheter aortic valve implant built on a low-profile nitinol frame with porcine pericardial tissue leaflets. The device’s locator architecture is designed to engage the native aortic leaflets to provide secure anchoring in regurgitant anatomy that lacks the calcified landing zone typically used for transcatheter valves indicated for aortic stenosis.

The approval is supported by the ALIGN-AR pivotal trial, which evaluated Trilogy in patients with symptomatic severe aortic regurgitation at prohibitive or high surgical risk. The trial demonstrated meaningful reductions in regurgitation severity at one year alongside acceptable safety endpoints, providing the first prospective evidence base for a dedicated AR transcatheter device in the United States.

JenaValve Technology develops transcatheter heart valve systems for the treatment of aortic regurgitation and aortic stenosis. The company is privately held and headquartered in Irvine, California.

Read further here

Solar Atmospheres expands California operations with new 10-bar vacuum furnace

Solar Atmospheres, Fontana, California, announced the installation and commissioning of a new 10-bar vacuum furnace at its California facility. Manufactured by sister company Solar Manufacturing, the horizontal furnace features a hot zone measuring 48-in. wide by 48-in. high by 96-in. deep, with a maximum load capacity of 12,000 pounds and an ultimate vacuum level of 1×10⁻⁶ Torr. The furnace expands the facility’s high-pressure quenching capabilities for processing titanium and high-performance alloys serving the aerospace, defense, medical, and power generation markets. “This investment gives our customers another regional solution for high-pressure quenching of large components and heavy workloads,” said Derek Dennis, President of Solar Atmospheres California.

Read further here

Boeing commits $7 million CAD to Vac Aero for vacuum furnace purchase

Boeing announced a $7 million CAD commitment to Vac Aero International Inc., a Canadian aerospace and defence supplier with operations in Ontario and Quebec, as part of the CP8A Poseidon Industrial and Technological Benefits (ITB) program. Boeing will purchase two vacuum furnaces for its Tube, Duct and Reservoir Center in Algona, Washington, where they will heat treat tube and duct assemblies critical to various Boeing airplane programs and select space and defense work. “This ITB investment underscores Boeing’s commitment to Canada following the CP8A Poseidon selection and to modern manufacturing and Canadian small businesses,” said Al Meinzinger, Boeing Canada President. Vac Aero CEO Michael Miasek noted the purchase commitment will allow the company to further expand its Canadian manufacturing capacity.

Read further here

Fort Wayne Metals receives Medtronic 2025 Supplier Innovation Excellence Award

Fort Wayne Metals, Fort Wayne, Indiana, received Medtronic’s 2025 Supplier Innovation Excellence Award for its nitinol melt program, which Medtronic recognized for strengthening global supply chain resilience and supporting the advancement of life-improving medical technologies.

Fort Wayne Metals is a fully integrated nitinol supplier, controlling every step of the manufacturing process from ingot melting through custom finishing of wires, tubes, and components. The company began working with nitinol in 1991 and established a dedicated melt facility in 2012. Between 2022 and 2024, production of melted nitinol for medical applications doubled, and a second vacuum arc remelting (VAR) furnace brought online in early 2025 positions the company to double output again. Melted nitinol now represents 74 percent of all nitinol products the company sells.

“Our goal is to enable our customers to develop their innovations, from nitinol melt to custom finishing of products,” said Scott Glaze, President and CEO of Fort Wayne Metals. The award reflects the company’s role as a critical upstream supplier to medical device manufacturers developing stents, guidewires, and implantable components that rely on nitinol’s unique superelastic and shape memory properties.

Fort Wayne Metals employs more than 2,000 people across its Fort Wayne, Indiana headquarters and facilities in Columbia City, Indiana, and Galway, Ireland.

[Read further here](https://www.medicaldesignandoutsourcing.com/medtronic-nitinol-supplier-fort-wayne-metals/)

Dynalloy transfers Flexinol actuator wire technology to insulin pump leader

Dynalloy Inc., Irvine, California, announced the transfer of its Flexinol actuator wire technology, equipment, personnel, and know-how to support vertical integration at one of the world’s largest providers of insulin pump delivery products. The agreement also includes exclusivity for direct-to-human drug delivery applications.

Flexinol actuator wires are made of nickel-titanium shape memory alloy and contract when electrically heated, functioning as compact, silent, lightweight actuators ideally suited for the precise mechanisms required in miniaturized medical devices. The technology transfer enables the insulin pump manufacturer to integrate advanced SMA actuator capabilities directly into its production operations.

In response to the transfer, Dynalloy has relocated to new state-of-the-art facilities to support increased Flexinol actuator wire manufacturing and related value-added products and sub-assemblies for its broader customer base spanning automotive, consumer electronics, aerospace, and industrial automation applications.

[www.dynalloy.com](https://www.dynalloy.com)

Integer to showcase neuromodulation innovations and fast-charge battery at NANS 2026

nteger Holdings Corporation, Plano, Texas, showcased its latest advancements in neuromodulation and next-generation miniaturized active implantable medical devices at the North American Neuromodulation Society Annual Meeting in Las Vegas, January 22-25, 2026.

The company highlighted the Xcellion Gen 3 Fast Charge lithium ion battery, which delivers best-in-class runtime and can recharge in as little as 30 minutes. Integer also demonstrated end-to-end contract development and manufacturing capabilities spanning high-performance batteries, fully integrated implantable pulse generators, and lead systems designed to accelerate development timelines and reduce risk for device companies bringing novel therapies to market.

“Miniaturization is transforming the future of implantable technologies, and we’re proud to partner with customers to make that future a reality,” said Jim Stephens, President of Cardiac Rhythm Management & Neuromodulation at Integer.

Integer Holdings is among the world’s largest medical device contract development and manufacturing organizations, serving cardiac rhythm management, neuromodulation, and cardiovascular markets. Its brands include Greatbatch Medical and Lake Region Medical.

[www.integer.net](https://www.integer.net)

Ilika completes first commercial Stereax electrode delivery to Cirtec Medical

Cirtec Medical, Brooklyn Park, Minnesota, has received the first commercial batch of Stereax solid-state battery electrodes from Ilika, Southampton, United Kingdom, for Stereax M300 production. The delivery fulfills the first revenue-generating order under a commercial supply arrangement initiated in January 2026.

The electrodes will support Stereax M300 batteries used in validation and customer sampling across multiple active implantable medical device categories, including implanted sensors, neurostimulators, orthopedic implants, orthodontic wearables, and ophthalmology devices. The Stereax M300 is an ultra-thin, millimeter-scale, rechargeable solid-state battery containing no liquid or polymer components, designed specifically for implantable applications.

“Our close technical cooperation with Ilika has developed into an effective operational partnership, ensuring customers receive the highest quality product for device integration,” said Shawn Martin, Vice President at Cirtec Medical.

Cathode manufacturing remains at Ilika’s UK facility as the most complex production step, while primary battery manufacturing occurs at Cirtec’s facility in Lowell, Massachusetts. The milestone marks Ilika’s transition from technology development to commercial supply in the medical device battery market.

[www.cirtecmed.com](https://www.cirtecmed.com)

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for nitinol fixation system

Smith+Nephew, Watford, United Kingdom, announced an exclusive US distribution agreement with RMR Ortho to add the A’TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle, and Hand & Wrist portfolio.

The A’TOMIC system leverages proprietary manufacturing methods and the unique properties of nitinol to provide compressive fixation implants featuring a wide bridge with barbed, round legs that match drill holes. The system is engineered to achieve stability of fusion, fracture, and osteotomy sites through high strength and active compression, designed to improve implant integrity and patient comfort.

“This partnership strengthens Smith+Nephew’s fixation portfolio by adding a dynamic compression fixation solution that complements our existing technologies,” said Scott Gunn, Vice President of U.S. Marketing, Trauma, Extremities, and Shoulder at Smith+Nephew. The agreement expands the company’s ability to participate in high-frequency fracture and arthrodesis procedures while leveraging established Extremities and Trauma sales channels.

“Partnering with Smith+Nephew represents an important step forward as we continue to expand access to the A’TOMIC Nitinol Fixation System across key U.S. territories,” said Joe Ritz, CEO of RMR Ortho.

Smith+Nephew is a global medical technology company operating in more than 100 countries with approximately 18,000 employees.

[www.smith-nephew.com](https://www.smith-nephew.com)